The Future of Patient Centricity
With the rising growth in speciality pharmaceuticals, patients have more treatment options than ever. However, these options come at a high cost. Reports show that specialty tier medications cost $40,500-95,000 per patient per year1, and co-pays for drugs on the specialty tier often range from 25% to 33%2. With cost as a major contributor to medication non-adherence, Pharamaceutical companies must find a way to give patients access to their therapies for the duration of treatment.
Innovative Support for the Business and the Patient
In an effort to support patient centricity, pharmaceutical companies offer a spectrum of patient support services ranging from basic patient education to disease management tools to fully integrated service programs providing financial, informational and emotional support. Innovators in Life Sciences are now tasked with finding creative ways to support the business while remaining patient centric. So how will patient centricity evolve in the next five years?
Here are a few ways you can optimize and innovate your current patient capabilities to drive greater health outcomes:
- Align stakeholders (patients, payers, providers) around a shared vision to understand patients’ needs and create a better experience
- Ensure tools and programs are aligned to solve a patient need while supporting the business objectives
- Leverage interaction data to get the right content and services to the right patients and providers, at the right time
Want to be prepared?
Now is the time to plan for the future of patient centricity within your organization. Schedule a complimentary consultation with a patient access specialist today.
1Stern D, Reissman D. Specialty pharmacy cost management strategies of private health care payers. J Manag Care Pharm. 2006;12:736-44.
2Puckrein GA, Wartman GC. Issue Brief 3. Specialty tiers: unequal treatment. National Minority Quality Forum. Available at: http://www.nmqf.org/issue-brief-specialtytiers-unequal-treatment/. Accessed June 23, 2014